Mode
Text Size
Log in / Sign up
Phase 2 N=23 Randomized Single-blind Treatment

Regional TAP Block for Bariatric Patients

Bariatric Surgery · Transverse Abdominal Plane Regional Blocks

Enrolled (actual)
23
Serious AEs
0.0%
Results posted
Dec 2019
Primary outcome: Primary: Post Operative Opioid Usage — 2.25; 4 morphine equivalent

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Transverse abdominal plane block (Procedure); Ropivacaine (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Montefiore Medical Center
Primary completion
May 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Post Operative Opioid Usage
2.25; 4
SECONDARY
Pain Score Assessed With Visual Analog Score (VAS)
5.5; 2
SECONDARY
Nausea: The Number of Participants Experiencing Nausea Will be Assessed by Chart Review
5; 3
SECONDARY
Vomiting: The Number of Participants Experiencing Vomiting Will be Assessed by Chart Review
0; 2

Summary

Addition of transverse abdominis plane (TAP) block to general anesthesia for morbidly obese patients (BMI >35) undergoing laparoscopic bariatric surgery for weight loss will significantly reduce opioid use in the recovery room

Eligibility Criteria

Inclusion Criteria

  • The patient must be 18 years of age or older and able to provide his or her own consent.
  • The patient is scheduled for bariatric surgery including laparoscopic gastric banding, sleeve gastrectomy, and gastric bypass.
  • The patient must be surgically and medically accepted for the procedure
  • Good functional status, ability to perform activities of daily living
  • The patients BMI > 35, no upper limit
  • Signed study specific informed consent prior to enrollment

Exclusion Criteria

  • Patients with an allergy to local anesthetics
  • Patients diagnosed with peripheral neuropathies including diabetes mellitus.
  • Patients with BMI <35
  • Patients with significant coronary artery disease
  • Patient refusal of block procedure.
  • Patients with chronic pain
  • Patients on pre-operative maintenance narcotics
  • American Society of Anesthesiologist classification system 4 (ASA 4) patients
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04051684). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search